Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Christophersen

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Human Vaccines & Immunotherapeutics|February 23, 2016
Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophilsKim Thomsen, Lars Christophersen, Peter Østrup Jensen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 26, 2026
Urinary Secretory-IgA and IgG Responses and Inflammatory Markers in Patients With Pseudomonas aeruginosa Urinary Tract InfectionsAyse Corap Cakmak, Niels Høiby, Lars Christophersen, et al.
International Journal of Molecular Sciences|July 5, 2017
Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic WoundsHannah Trøstrup, Christian Johann Lerche, Lars Christophersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 20, 2022
Murine burn lesion model for studying acute and chronic wound infectionsHenrik Calum, Hannah Trøstrup, Anne Sofie Laulund, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 25, 2016
Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in miceDina Silke Malling Damlund, Lars Christophersen, Peter Østrup Jensen, et al.
International Journal of Antimicrobial Agents|December 1, 2020
Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection modelKim Thomsen, Lars Christophersen, Christian Johann Lerche, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 21, 2023
Biofilm formation on endovascular aneurysm repair (EVAR) grafts-a proof of concept in vitro modelTorgny Sunnerhagen, Franziska Schwartz, Lars Christophersen, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2015
Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm modelBao Cao, Lars Christophersen, Kim Thomsen, et al.
Plos One|April 22, 2016
Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm ModelBao Cao, Lars Christophersen, Mette Kolpen, et al.
Archives of Dermatological Research|April 17, 2016
S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitusHannah Trøstrup, Per Holstein, Lars Christophersen, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Human Vaccines & Immunotherapeutics|February 23, 2016
Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophilsKim Thomsen, Lars Christophersen, Peter Østrup Jensen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 26, 2026
Urinary Secretory-IgA and IgG Responses and Inflammatory Markers in Patients With Pseudomonas aeruginosa Urinary Tract InfectionsAyse Corap Cakmak, Niels Høiby, Lars Christophersen, et al.
International Journal of Molecular Sciences|July 5, 2017
Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic WoundsHannah Trøstrup, Christian Johann Lerche, Lars Christophersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 20, 2022
Murine burn lesion model for studying acute and chronic wound infectionsHenrik Calum, Hannah Trøstrup, Anne Sofie Laulund, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 25, 2016
Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in miceDina Silke Malling Damlund, Lars Christophersen, Peter Østrup Jensen, et al.
International Journal of Antimicrobial Agents|December 1, 2020
Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection modelKim Thomsen, Lars Christophersen, Christian Johann Lerche, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 21, 2023
Biofilm formation on endovascular aneurysm repair (EVAR) grafts-a proof of concept in vitro modelTorgny Sunnerhagen, Franziska Schwartz, Lars Christophersen, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2015
Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm modelBao Cao, Lars Christophersen, Kim Thomsen, et al.
Plos One|April 22, 2016
Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm ModelBao Cao, Lars Christophersen, Mette Kolpen, et al.
Archives of Dermatological Research|April 17, 2016
S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitusHannah Trøstrup, Per Holstein, Lars Christophersen, et al.
Pageof 3